If a patient is allergic to codeine, what alternative analgesics can be used?

Alternative Analgesics for Patients with Codeine Allergy

For patients allergic to codeine, NSAIDs (ibuprofen 400–600 mg or naproxen) should be the first-line therapy for mild-to-moderate pain, and when opioids are required, tramadol, oxycodone, hydrocodone, morphine, fentanyl, or hydromorphone are all safe alternatives that do not cross-react with codeine allergy. 1

First-Line Non-Opioid Options for Mild-to-Moderate Pain

• Ibuprofen 400 mg is the preferred initial analgesic, achieving superior efficacy (NNT = 2.7) compared to codeine-acetaminophen combinations (NNT = 4.4), with fewer adverse effects and longer duration before re-medication is needed. 1, 2

• Naproxen or other NSAIDs provide equivalent analgesia and can be used when ibuprofen is not tolerated, though they have not consistently demonstrated superior efficacy to ibuprofen. 2

• Celecoxib 400 mg (a COX-2 selective NSAID) offers excellent efficacy with NNT = 2.5 and prolongs time to repeat dosing (average 8.4 hours vs 4.1 hours for codeine-acetaminophen). 1

• Acetaminophen 1000 mg every 4–6 hours (maximum 4 g/24 hours) is an acceptable alternative when NSAIDs are contraindicated due to gastrointestinal, renal, or cardiovascular risk. 2

Opioid Alternatives When Stronger Analgesia Is Required

For Mild-to-Moderate Pain Requiring Opioids:

• Oxycodone-acetaminophen (5–10 mg oxycodone every 4–6 hours) provides marginally better pain relief than codeine-acetaminophen with comparable tolerability, making it a reasonable first-choice opioid alternative. 1, 3

• Hydrocodone-acetaminophen (5–15 mg hydrocodone every 4–6 hours) is more effective than codeine-acetaminophen for chronic pain and demonstrates significantly fewer treatment failures and less CNS side effects (sedation, lightheadedness) in acute musculoskeletal pain. 1, 4

• Tramadol should be avoided because its analgesic efficacy is inferior to morphine, it has a narrow therapeutic window with seizure risk, and it interacts dangerously with serotonergic agents (risk of serotonin syndrome). 1, 2

For Moderate-to-Severe Pain:

• Oral morphine remains the first-line strong opioid for moderate-to-severe cancer pain and should be given without delay when pain is uncontrolled by step 1 and 2 treatments. 5, 1

• Immediate-release hydromorphone or oxycodone are acceptable alternatives when morphine is contraindicated or not tolerated. 1

• Low-dose strong opioids combined with non-opioid analgesics are favored over weak opioids like codeine for better pain control and safety. 6, 1

Parenteral Opioid Options for Severe Acute Pain

• Fentanyl (1 µg/kg initial bolus, then ~30 µg every 5 minutes) is preferred over morphine for rapid analgesia because it has faster onset, is approximately 100-fold more potent, and does not cross-react in patients allergic to morphine. 1

• Hydromorphone 0.015 mg/kg IV provides analgesia comparable to or superior to morphine 0.1 mg/kg IV, with quicker onset and minimal histamine release, making it safe for patients with type 2 (non-IgE) morphine allergy. 1

Critical Safety Considerations

Cross-Reactivity and Allergy Management:

• True IgE-mediated allergy to codeine is rare; many reported cases are actually morphine hypersensitivity or non-immune-mediated reactions. 1, 7

• Fentanyl exhibits no cross-reactivity with morphine allergies, providing a reliable alternative for allergic patients. 1

• In patients with documented type 2 (non-IgE) morphine allergy, hydromorphone can be administered safely without triggering histamine-mediated reactions. 1

Pharmacogenomic Considerations:

• Codeine requires conversion to morphine by CYP2D6; poor metabolizers receive inadequate analgesia while ultra-rapid metabolizers are at risk of toxicity, making it an unreliable analgesic regardless of allergy status. 1, 8

• Concomitant use of CYP2D6 inhibitors markedly reduces the analgesic effect of codeine, further limiting its utility. 1

Renal Impairment Guidance:

• Codeine, morphine, and meperidine should be avoided in severe renal impairment (eGFR < 30 mL/min/1.73 m²) because active metabolites accumulate. 1

• Fentanyl and buprenorphine (transdermal or IV) are the safest opioid options for chronic kidney disease stages 4–5. 6, 1

• Hydrocodone, oxycodone, and hydromorphone may be used with dose adjustments and close monitoring in renal insufficiency. 1

Common Pitfalls to Avoid

• Do not assume codeine is safer because it is a Schedule III drug; its analgesic effect is unpredictable due to CYP2D6 genetic variability, and adverse-event rates are similar to other opioids. 1, 8

• Do not prescribe tramadol as a "safer" alternative; it has inferior efficacy, narrow therapeutic window, and significant drug interaction risks. 1, 2

• Avoid combining opioids from different receptor categories (pure agonist, partial agonist-antagonist, or mixed agonist-antagonist) as they should not be prescribed simultaneously. 5

• Always anticipate constipation with all opioids (not just codeine) and prescribe laxatives routinely for prophylaxis. 5, 6